- |||||||||| Menveo (meningococcal-groups A, C, W-135 and Y oligosaccharide CRM197 conjugate vaccine) / GSK
Trial completion, Enrollment change, Trial primary completion date: Understanding the Immune Response to Two Different Meningitis Vaccines (clinicaltrials.gov) - Nov 9, 2015 P4, N=20, Completed, Active, not recruiting --> Completed | N=15 --> 20 | Trial primary completion date: Dec 2013 --> Apr 2013
- |||||||||| Trial completion: Early-Onset Sepsis Surveillance Study (clinicaltrials.gov) - Nov 9, 2015
P=N/A, N=615, Completed, Active, not recruiting --> Completed | N=15 --> 20 | Trial primary completion date: Dec 2013 --> Apr 2013 Active, not recruiting --> Completed
- |||||||||| Enrollment change, Trial withdrawal, Trial primary completion date: DAMSEL2: Dose Assessment of Melatonin in Sepsis Trial (clinicaltrials.gov) - Nov 6, 2015
P1/2, N=0, Withdrawn, Active, not recruiting --> Completed N=50 --> 0 | Active, not recruiting --> Withdrawn | Trial primary completion date: Nov 2016 --> Dec 2014
- |||||||||| tigecycline / Generic mfg., acetylcysteine solution / Generic mfg.
Trial withdrawal: Treatment of Hemodialysis Catheter-Related Bacteremia (clinicaltrials.gov) - Oct 23, 2015 P2/3, N=0, Withdrawn, Trial primary completion date: Oct 2014 --> Oct 2015 Not yet recruiting --> Withdrawn
- |||||||||| Prezista (darunavir) / J&J, Isentress (raltegravir) / Merck (MSD)
Enrollment change, Trial termination, Trial primary completion date: Management of Participants With Low-level Persistent Viremia (ANRS 161 L-VIR) (clinicaltrials.gov) - Oct 22, 2015 P3, N=4, Terminated, Recruiting --> Active, not recruiting N=120 --> 4 | Recruiting --> Terminated | Trial primary completion date: Mar 2017 --> Sep 2015; Low recruitment of participants for the study
- |||||||||| Enrollment closed, Trial initiation date, Trial primary completion date: EIDECS: End-of-life Decision-making in Patients With Sepsis-related Organ Failure (clinicaltrials.gov) - Oct 15, 2015
P=N/A, N=180, Active, not recruiting, N=120 --> 4 | Recruiting --> Terminated | Trial primary completion date: Mar 2017 --> Sep 2015; Low recruitment of participants for the study Recruiting --> Active, not recruiting | Initiation date: Dec 2010 --> Aug 2010 | Trial primary completion date: Jun 2014 --> Oct 2014
- |||||||||| Leukine (sargramostim) / Partner Therap
Trial completion, Trial primary completion date: Does GM-CSF Restore Neutrophil Phagocytosis in Critical Illness? (clinicaltrials.gov) - Oct 7, 2015 P1/2, N=70, Completed, Recruiting --> Active, not recruiting | Initiation date: Dec 2010 --> Aug 2010 | Trial primary completion date: Jun 2014 --> Oct 2014 Recruiting --> Completed | Trial primary completion date: Apr 2015 --> Jan 2015
- |||||||||| Enrollment change, Trial termination, Trial primary completion date: Studies of Acute Lung Injury (ALI) and Acute Respiratory Distress Syndrome (clinicaltrials.gov) - Oct 6, 2015
P1, N=28, Terminated, Active, not recruiting --> Completed | N=1120 --> 518 N=40 --> 28 | Active, not recruiting --> Terminated | Trial primary completion date: Dec 2012 --> Sep 2014; Inability to recruit the patients due to the short supply and changed local hospital protocol
- |||||||||| tacrolimus intravenous / Generic mfg., mycophenolate mofetil / Generic mfg., sirolimus / Generic mfg.
Enrollment closed, Enrollment change: Using mTOR Inhibitors in the Prevention of BK Nephropathy (clinicaltrials.gov) - Oct 2, 2015 P=N/A, N=41, Active, not recruiting, N=40 --> 28 | Active, not recruiting --> Terminated | Trial primary completion date: Dec 2012 --> Sep 2014; Inability to recruit the patients due to the short supply and changed local hospital protocol Recruiting --> Active, not recruiting | N=60 --> 41
- |||||||||| Trial primary completion date: Serial Therapeutic and Antifungal Monitoring Protocol (clinicaltrials.gov) - Sep 28, 2015
P=N/A, N=60, Recruiting, Recruiting --> Completed | Trial primary completion date: Apr 2015 --> Aug 2015 Trial primary completion date: Apr 2015 --> Jun 2016
- |||||||||| vancomycin / Generic mfg.
Trial primary completion date: RCT of Continuous Versus Intermittent Infusion of Vancomycin in Neonates (clinicaltrials.gov) - Sep 25, 2015 P=N/A, N=200, Recruiting, Not yet recruiting --> Recruiting | Initiation date: Mar 2015 --> Sep 2015 | Trial primary completion date: Apr 2016 --> Sep 2016 Trial primary completion date: Sep 2016 --> Sep 2017
- |||||||||| Enrollment change, Trial primary completion date: Early PREdiction of Severe Sepsis I (ExPRES-Sepsis I) Study (clinicaltrials.gov) - Sep 25, 2015
P=N/A, N=500, Recruiting, Trial primary completion date: Sep 2016 --> Sep 2017 N=200 --> 500 | Trial primary completion date: Jul 2015 --> Dec 2015
- |||||||||| Trial completion, Trial primary completion date: German Lactat Clearance in Severe Sepsis (clinicaltrials.gov) - Sep 25, 2015
P=N/A, N=300, Completed, N=200 --> 500 | Trial primary completion date: Jul 2015 --> Dec 2015 Recruiting --> Completed | Trial primary completion date: Jan 2014 --> Apr 2015
- |||||||||| Enrollment closed, Trial primary completion date: Near Infrared Spectroscopy (St02) (clinicaltrials.gov) - Sep 10, 2015
P=N/A, N=300, Active, not recruiting, Not yet recruiting --> Recruiting | Trial primary completion date: Jun 2015 --> Mar 2016 Recruiting --> Active, not recruiting | Trial primary completion date: Sep 2010 --> Sep 2016
- |||||||||| simvastatin / Generic mfg.
Trial completion, Enrollment change, Trial primary completion date: Statin Therapy in the Treatment of Sepsis (clinicaltrials.gov) - Sep 9, 2015 P2/3, N=13, Completed, Recruiting --> Completed Recruiting --> Completed | N=60 --> 13 | Trial primary completion date: Dec 2013 --> Dec 2010
- |||||||||| Trial completion, Trial primary completion date: Ubiquinol (Reduced COQ10) for Patients With Sepsis (clinicaltrials.gov) - Sep 8, 2015
P2, N=38, Completed, Recruiting --> Completed Recruiting --> Completed | Trial primary completion date: Dec 2013 --> Apr 2014
- |||||||||| Trial primary completion date: The Paediatric Refill Study (PRefill) (clinicaltrials.gov) - Aug 22, 2015
P=N/A, N=135, Recruiting, N=120 --> 80 Trial primary completion date: May 2015 --> Dec 2015
- |||||||||| Trial initiation date, Trial primary completion date: Actigraphy to MEasuRe Intensive Care Unit Activity (clinicaltrials.gov) - Aug 13, 2015
P=N/A, N=75, Recruiting, Completed --> Terminated; Not participants inclusion Initiation date: Oct 2014 --> Jul 2015 | Trial primary completion date: Sep 2015 --> Dec 2015
- |||||||||| Phase classification, Trial initiation date, Trial primary completion date: Post Marketing Surveillance Study To Observe Safety And Efficacy Of Eraxis® IV (clinicaltrials.gov) - Aug 13, 2015
P=N/A, N=200, Active, not recruiting, Initiation date: Oct 2014 --> Jul 2015 | Trial primary completion date: Sep 2015 --> Dec 2015 Phase classification: P4 --> P=N/A | Initiation date: Mar 2012 --> Aug 2012 | Trial primary completion date: Jul 2015 --> Feb 2016
- |||||||||| fludrocortisone / Generic mfg., hydrocortisone / Generic mfg.
Trial completion, Trial primary completion date: APROCCHS: Activated Protein C and Corticosteroids for Human Septic Shock (clinicaltrials.gov) - Aug 12, 2015 P3, N=1241, Completed, Phase classification: P4 --> P=N/A | Initiation date: Mar 2012 --> Aug 2012 | Trial primary completion date: Jul 2015 --> Feb 2016 Recruiting --> Completed | Trial primary completion date: Dec 2014 --> Jun 2015
- |||||||||| Enrollment closed: SIFT: Speed of Increasing Milk Feeds Trial (clinicaltrials.gov) - Aug 12, 2015
P=N/A, N=2806, Active, not recruiting, N=128 --> 40 | Active, not recruiting --> Terminated | Trial primary completion date: Aug 2013 --> Apr 2013; Problems implementing the trial Recruiting --> Active, not recruiting
|